The Relationship of Serum S100B Levels with Infarction Size and Clinical Outcome in Acute Ischemic Stroke Patients


Selcuk O., Yayla V., Cabalar M., Guzel V., Uysal S., GEDİKBAŞI A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, cilt.51, sa.4, ss.395-400, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 51 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5152/npa.2014.7213
  • Dergi Adı: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.395-400
  • Anahtar Kelimeler: Brain, cerebrovascular disorders, biological markers, prognosis, NEURON-SPECIFIC ENOLASE, S-100 PROTEIN, BRAIN-DAMAGE, NEUROBIOCHEMICAL MARKERS, VOLUME, BLOOD
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Introduction: S100B protein, which helps nerve development and differentiation, is produced by astrocytes and can be detected in peripheral circulation after brain damage. In this study, we aimed to investigate the relationship between the serum S100B protein level and the infarction volume and clinical outcome and also the early prognostic role of serum S100B protein in patients with ischemic stroke.